Ontology highlight
ABSTRACT:
PROVIDER: PRJNA793295 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Uncaria rhynchophylla Raw sequence reads
| PRJNA792441 | ENA
Project description:Uncaria rhynchophylla Transcriptome or Gene expression
| PRJNA222281 | ENA
Project description:Uncaria rhynchophylla Transcriptome or Gene expression
| PRJNA222282 | ENA
Project description:Uncaria rhynchophylla Transcriptome or Gene expression
| PRJNA222280 | ENA
Project description:Uncaria rhynchophylla Transcriptome or Gene expression
| PRJNA222278 | ENA
Project description:SMRT ChIP-seq were performed to identify binding site of SMRT in CD8α+ DCs at 0hr and 6hr CpG stimulation.
2022-09-20 | E-MTAB-10069 | biostudies-arrayexpress
Project description:ChIP-seq of mouse embryonic fibroblast-adipose like cell line 3T3-L1 to identify binding sites of NCoR1 and SMRT following induction of differentiation, and RNA Pol-II after SMRT knock down
2012-04-23 | E-MTAB-1031 | biostudies-arrayexpress
Project description:BCL6 is crucial for B-cell activation and lymphomagenesis. We used integrative genomics to explore BCL6 mechanism in normal and malignant B-cells. Surprisingly, BCL6 assembled distinct complexes at enhancers vs. promoters. At enhancers BCL6 preferentially recruited SMRT, which mediated H3K27 deacetylation through HDAC3, antagonized p300 activity and repressed transcription, but without decommissioning enhancers. This provides a biochemical basis for toggling enhancers from the active to poised state. Virtually all SMRT was bound with BCL6 suggesting that in B-cells BCL6 uniquely sequesters SMRT from other factors. In promoters BCL6 preferentially recruited BCOR, but most potently repressed promoters where it formed a distinctive ternary complex with SMRT and BCOR. Promoter repression was associated with decreased H3K36me3, H3K79me2 and Pol II elongation, linking BCL6 to transcriptional pausing. We identified the binding patterns of BCL6, SMRT, NCOR and BCOR corepressors in normal germinal center B cells and a DLBCL cell line (OCI-Ly1) using ChIP-seq. Additionally we treated lymphoma cells with siRNA against BCL6 and a non-targeted siRNA (NT control) and performed RNA-seq to identify the genes bound and repressed by BCL6. RNA-seq experiments were performed at 24h and 48h after siRNA treatments. Additional biological triplicate RNA-seq experiments were performed at 48h after BCL6 knockdown. Furthermore, a series of histone mark ChIP-seq and RNA polymerase ChIP-seq (total, Ser5-P and Ser2-P) were preformed to capture the chromatin states associated with the formation of BCL6 corepressor complexes.
2013-08-05 | E-GEOD-29282 | biostudies-arrayexpress